Global Pharmacovigilance Market to Reach US$6.1 bn by 2020 Owing to Increasing Consumption of Drugs: Transparency Market Research

Mar 18, 2016, 13:30 ET from Transparency Market Research

ALBANY, New York, March 18, 2016 /PRNewswire/ --

Transparency Market Research has published a new report on the global pharmacovigilance market. As per the report, the global pharmacovigilance market stood at US$2.4 bn in 2013 and is predicted to reach US$6.1 bn by 2020. The report, titled 'Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020', states that the global pharmacovigilance market is expected to rise at a 14.20% CAGR between 2014 and 2020.

Pharmacovigilance is a crucial component of an effective drug regulation system and is used for evaluating and monitoring adverse drug reactions. Pharmacovigilance activities are essential for conducting clinical research. Currently, the global network of pharmacovigilance centers is operating effectively to assure appropriate functioning of drug safety procedures. The large volume of international adverse drug reaction reports collected and stored in a central database assists the national drug regulatory authorities to improve the safety profiles of various drugs. This is expected to help avoid disasters associated with drugs. Growing expectations regarding the safe use of drugs and increasing health awareness among people have propelled the global pharmacovigilance market in the recent past.

Request Industry Research Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729

The growing number of pharmacovigilance centers worldwide is playing a key role in spreading awareness among people about safe use of drugs. Web-based sales of drugs, unavailability of knowledgeable people, and high data security risk are some of the possible factors expected to restrict the growth of the global pharmacovigilance market in the years to come. However, factors such as strict regulatory expectations, immediate need for patient reporting, and tough drug inspection systems are expected to propel the global pharmacovigilance market in the coming few years.

The global pharmacovigilance market is segmented on the basis of phase of drug development, region, type of method, and type of service. Based on phase of drug development, the global pharmacovigilance market is classified into preclinical studies, phase I, phase II, phase III, and phase IV or post-marketing surveillance. In 2013, the phase IV or post-marketing surveillance segment held a 60% share in the global pharmacovigilance market and is expected to maintain its dominant position by 2020. Factors such as the need to conduct risk assessment studies at the time of crucial stages of drug development, development of comparative safety data, and the valuation of medication errors are some of the factors expected to help expand the phase III clinical trial segment in the years to come.

Browse Research Report with TOC & Free Analysis: http://www.transparencymarketresearch.com/pharmacovigilance-market.html

Based on the type of service, the global pharmacovigilance market was dominated by the outsourcing segment, accounting for more than 50% of the total pharmacovigilance market, in 2013. By region, in 2013, North America held the largest share of 35% in the global pharmacovigilance market.

The global pharmacovigilance market is highly competitive and fragmented. The rapid growth of the global pharmacovigilance market is expected to attract many CROs and BPOs from across the world. Some of the leading players in the global pharmacovigilance market are Covance, Inc., Quintiles Transnational Holdings, Inc., Cognizant Technology Solutions, Pharmaceutical Product Development, LLC, (PPD), Novartis International AG, PAREXEL International Corporation, F. Hoffmann-La Roche Ltd., Accenture plc, GlaxoSmithKline plc, and Wipro Limited.

Browse Market Research Article: http://www.transparencymarketresearch.com/article/pharmacovigilance-market.htm

Key Segments of Global Pharmacovigilance Market 

Pharmacovigilance Market, by Phases of Drug Development 

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance 

Pharmacovigilance Market, by Types of Methods  

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance Market, by Type of Service 

  • In-house
  • Contract Outsourcing

Pharmacovigilance Market, by Geography 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Other Trending Reports by TMR: 

  • Foot and Mouth Disease Vaccines Market:  

http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html  

  • Peptide Therapeutics Market:  

http://www.transparencymarketresearch.com/peptide-therapeutics-market.html  

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:
Mr. Sudip. S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/


SOURCE Transparency Market Research